SCHEMBL3159151

SCHEMBL3159151

CCc1ccc2cc(-c3cc(F)cc(F)c3)ccc2c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP2A6 P11509 1/20 0.52
PGR P06401 1/20 0.44
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
CYP17A1 P05093 2/20 0.41
CYP21A2 P08686 1/20 0.41
CYP11B1 P15538 1/20 0.41
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
TAAR1 Q96RJ0 2/20 0.38
HRH3 Q9Y5N1 4/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
LMNA P02545 1/20 0.36
TRPA1 O75762 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3158255 0.98 CYP1A2 (0.50) CYP1A2CYP2A6PGRFGFR1FGFR2
SCHEMBL3257252 0.91 CYP1A2 (0.43) CYP1A2CYP2A6PGRFGFR1FGFR2
SCHEMBL3257876 0.87 CYP1A2 (0.43) CYP1A2CYP2A6PGRFGFR1FGFR2
SCHEMBL3157962 0.87 CYP1A2 (0.53) CYP1A2CYP2A6PGRCYP17A1AKR1C3
SCHEMBL3166607 0.87 CYP1A2 (0.53) CYP1A2CYP2A6PGRCYP17A1AKR1C3
SCHEMBL3163338 0.86 TAAR1 (0.56) CYP1A2CYP2A6CYP17A1CYP11B1TAAR1
SCHEMBL3162709 0.86 HRH3 (0.43) CYP1A2CYP2A6PGRFGFR1FGFR2
SCHEMBL3153225 0.84 CYP17A1 (0.45) PGRFGFR1FGFR2CYP17A1CYP21A2
SCHEMBL3158271 0.84 TAAR1 (0.59) CYP1A2CYP2A6CYP17A1CYP11B1TAAR1
SCHEMBL3158603 0.84 CYP1A2 (0.50) CYP1A2CYP2A6CYP17A1CYP11B1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2010-03-31 EP disclosed
EP-1273562-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2009-07-22 EP disclosed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed
EP-0952135-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 CYP1A2 959/4885CYP2A6 3496/4885PGR 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.